DARA BioSciences Inc (NASDAQ:DARA)
| 0.73 Data as of 1:43pm ET |  -0.03 / -3.95%Today’s Change | 0.62 Today|||52-Week Range 1.38 | -5.19% Year-to-Date |
Latest DARA News | Press Releases
No recent news for DARA BioSciences Inc.
Today’s Trading
| Previous close | 0.76 |
| Today’s open | 0.76 |
| Day’s range | 0.72 - 0.76 |
| Volume | 93,967 |
| Average volume (3 months) | 461,852 |
| Market cap | $19.0M |
| Dividend yield | -- |
Data as of 1:43pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | +46.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 173.88 |
| Price/Book | 1.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MSLIMerus Labs Internati... | -0.08 | -11.26% |
| TNXPDTonix Pharmaceutical... | -0.98 | -13.10% |
| TZYMTranzyme Inc | -0.00 | -0.12% |
| NVGNNovogen Ltd | +0.00 | +0.00% |
Data as of 2:02pm ET, 05/23/2013
Financials
| Last reporting date | May 23, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $53.6K |
| Annual profit (last year) | -$7.3M |
| Net profit margin | -13,632.61% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Operating Officer & Director Christopher G. Clement |
Director, Chief Executive & Medical Officer David J. Drutz, MD |
Corporate headquarters Raleigh, North Carolina |
Forecasts
